Dear Reader,

As we reach the final issue of *Drugs in R&D* for 2018, we wish to reflect on another successful year's achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

2018 was a successful year for *Drugs in R&D*. Over 30 articles have been published; the most popular of these, in terms of downloads from SpringerLink, have been:

Rodrígues-Portal J.A. [Efficacy and Safety of Nintedanib for the Treatment of Idiopathic pulmonary fibrosis: An update](https://link.springer.com/content/pdf/10.1007%2Fs40268-017-0221-9.pdf).

Auffret M, Drapier S, Vérin M. [The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future](https://link.springer.com/content/pdf/10.1007%2Fs40268-018-0230-3.pdf).

Buoli, M, Serati, M, Botturi A, Altamura AC. [The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data](https://link.springer.com/content/pdf/10.1007%2Fs40268-017-0224-6.pdf).

Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. [Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication](https://link.springer.com/content/pdf/10.1007%2Fs40268-018-0231-2.pdf).

Piwnica D, Pathak A, Schäfer, Docherty JR. [In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea](https://link.springer.com/content/pdf/10.1007%2Fs40268-018-0227-y.pdf).

Liebl A, Mohan V, Yang W, Krzysztof S, Linjawi S. [15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes](https://link.springer.com/content/pdf/10.1007%2Fs40268-018-0228-x.pdf).

Garimella T, Tao, X, Sims K, Yi-Ting C, Rana J, Myers E, Wind-Rotolo M, Bhatnagar R, Eley T, LaCreta F, AbuTarif M. [Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects](https://link.springer.com/content/pdf/10.1007%2Fs40268-017-0222-8.pdf).

Solowij N, Galettis P, Broyd SJ, de Krey P, Martin JH. [Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting](https://link.springer.com/content/pdf/10.1007%2Fs40268-017-0225-5.pdf).

López-Cedrún J, Videla S, Burgueño M, Juárez I, Aboul-Hosn S, Martín-Granizo R, Grau J, Puche M, Gil-Diez J, Hueto JA, Vaqué A, Sust M, Plata-Salamán C, Monner A. [Co-crystal of Tramadol--Celecoxib in Patients with Moderate to Severe Acute Post-surgical Oral Pain: A Dose-finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre, Phase II Trial](https://link.springer.com/content/pdf/10.1007%2Fs40268-018-0235-y.pdf).

Chen JJ, Hewitt LA. [Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects](https://link.springer.com/content/pdf/10.1007%2Fs40268-018-0226-z.pdf).

The quality of articles published in the journal is also reflected in its most recent Citescore (2.3). Based on this Citescore *Drugs in R&D* is ranked 125th among 329 journals in the 'Pharmacology' Category.

Other journals in the Adis Premier Journals Portfolio (<http://www.springer.com/gp/adis>) continue to prosper with substantial increases in usage year on year. In addition, this year has seen *Applied Health Economics and Health Policy* receive its first impact factor.

We thank the authors who have contributed articles to *Drugs in R&D* over the course of 2018. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal's content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for *Drugs in R&D* in the last 12 months:

Mohd Hafiz Abdul Aziz, Australia

Guohua An, USA

Emmanuel Bäckryd, Sweden

Edward Bastyr, USA

Hannah K. Batchelor, UK

Ahmad Beydoun, Lebanon

Rodolfo Eduardo Bordoni, USA

Arjan Bredenoord, The Netherlands

Döndü Cansu, Turkey

Brett J. Carroll, USA

Noel C. Chan, Canada

Pier Giorgio Cojutti, Italy

Adam Collison, Australia

Ranjeet Prasad Dash, USA

Fernando Augusto de Lima Marson, Brazil

Renato De Vecchis, Italy

David Devos, France

Makoto Endo, Japan

Linda Felton, USA

Gloria Formoso, Italy

Raffaele Giusti, Italy

Steven Greenway, Canada

Thomas Greuter, USA

Christian Höcht, Argentina

Rebecca L. Hartman, USA

Simon Hill, UK

Zhe Hui Hoo, UK

Florenzo Iannone, Italy

Yoshihiko Kanno, Japan

Jothydev Kesavadev, India

Abhilash Koratala, USA

Dirk Kropeit, Germany

Rutuja Kulkarni, USA

Stuart Lieblich, USA

Wei Liu, USA

Lukas Lofling, Sweden

Vincent Maida, Canada

Francisco Marin, Spain

Sean McAllister, USA

Janthima Methaneethorn, Thailand

Giuseppe Micali, Italy

Pawel Mierzejewski, Poland

Andrew R. A. Moore, UK

Hiroshi Nagayama, Japan

Cade Nylund, USA

Onur Ozturk, Turkey

Manjunath P. Pai, USA

Rosa Maria Paragliola, Italy

Deven Parmar, India

Nupur Patel, USA

Nitipong Pempalung, USA

Santiago Perez-Lloret, Argentina

Goran Petrovski, Republic of North Macedonia

Cameron Phillips, Australia

Birk Poller, Switzerland

Ronald Reed, USA

Bernhard Resch, Austria

Hanno B. Riess, Germany

Antonio A. Rossi, Italy

Makoto Saito, UK

Cristina Sanches, Brazil

Helmut Schütz, Austria

Jan-Frederik Schlender, Germany

Alec Schmaier, USA

Ravi Shankar, USA

Joanne Louise Sharp, UK

Jordan Smith, USA

Konstantina Soulele, Greece

Edyta Szalek, Poland

Konstantinos Thomas, Greece

Nataliya Titova, The Russian Federation

Laszlo Tothfalusi, Hungary

Teresa Christina Gomes Alfinito Vieira, Brazil

Hiroki Wakabayashi, Japan

Thomas J. Walsh, USA

Eric Wenzler, USA

Yuichi Yoshida, Japan

In addition, we would like to thank the members of the journal's Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

G. An, University of Iowa, Iowa, IA, USA

R. K. Campbell, Washington State University, Pullman, WA, USA

D. Cattaneo, Luigi Sacco University Hospital, Milan, Italy

G. Cherala, Eastern Virginia Medical School, Norfolk, VA, USA

R. P. Dash, Johns Hopkins School of Medicine, Baltimore, MD, USA

Y.K. Gupta, All India Institute of Medical Sciences, New Delhi, India

H. P. Hartung, Heinrich-Heine University, Dusseldorf, Germany

C. Höcht, University of Buenos Aires, Buenos Aires, Agentina

N. M. Idkaidek, University of Petra, Amman, Jordan

F. Jamali, University of Alberta, Edmonton, AB, Canada

T. K. L. Kiang, The University of British Columbia, Vancouver, BC, Canada

M. J. McKeage, University of Auckland, Auckland, New Zealand

P. J. Nathan, Monash University, Melbourne, VIC, Australia

B. M. Patel, Nirma University, Ahmedabad, India

S. Perez-Lloret, Institute for Cardiology Research, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina

M. Pfister, University of Basel, Basel, Switzerland

G. Remington, University of Toronto, Toronto, ON, Canada

H. Schütz, BEBAC Consulting, Vienna, Austria

M. H. Shishehbor, Cleveland Clinic Cardiovascular Disease, Cleveland, OH, USA

L. P. Shulman, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA

L. Tóthfalusi, Semmelweis University, Budapest, Hungary

J. Weiss, University of Heidelberg, Heidelberg, Germany

We do hope that you have found the articles published throughout the year in*Drugs in R&D* to be interesting and informative. The editorial schedule for 2019 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

With best wishes,

Anton van Rensburg

Editor,

*Drugs in R&D*
